163 related articles for article (PubMed ID: 25584234)
1. Waldenstroms Macroglobulinemia Patient Presenting with Rare 'lytic' Lesions and Hypercalcemia: A Diagnostic Dilemma.
Mehmood K; Naqvi IH; Shah SR; Zakir N; Ali SM
J Clin Diagn Res; 2014 Nov; 8(11):FD10-1. PubMed ID: 25584234
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Tools of Waldenströms Macroglobulinemia - Best Possibilities for Non-invasive and Long-term Disease Monitoring.
Growkova K; Kufová Z; Sevcikova T; Filipová J; Kascak M; Jelínek T; Grosicki S; Barchnicka A; Roziaková Ľ; Mistrík M; Simicek M; Hájek R
Klin Onkol; 2017; 30(Supplementum2):81-91. PubMed ID: 28903575
[TBL] [Abstract][Full Text] [Related]
3. IgM Myeloma: An IgM Gammopathy Distinct from Waldenstrom's Macroglobulinemia.
Nordquist LT; Saba HI; Moscinski LC
Hematology; 2001; 6(1):53-8. PubMed ID: 27419604
[TBL] [Abstract][Full Text] [Related]
4. IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom's macroglobulinemia.
Schuster SR; Rajkumar SV; Dispenzieri A; Morice W; Aspitia AM; Ansell S; Kyle R; Mikhael J
Am J Hematol; 2010 Nov; 85(11):853-5. PubMed ID: 20842638
[TBL] [Abstract][Full Text] [Related]
5. Bone Involvement as a Primary Rare Manifestation of Waldenstrom Macroglobulinemia: A Case Report and Prevalence in a Nationwide Population-Based Cohort Study.
Bhatti K; Nazir A; Ostergaard S; Schejbel L; Norgaard P; Gjerdrum LMR; Moghaddas M; Nielsen TH; Munksgaard L; Pedersen LM
J Hematol; 2022 Dec; 11(6):233-239. PubMed ID: 36632577
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy of undetermined significance and solitary plasmacytoma. Implications for progression to overt multiple myeloma.
Kyle RA
Hematol Oncol Clin North Am; 1997 Feb; 11(1):71-87. PubMed ID: 9081205
[TBL] [Abstract][Full Text] [Related]
8. Waldenstrom Macroglobulinemia: Clinical Presentation, Diagnosis, and Management in an Elderly Male.
Shahab S; Semerdzhiev DI; Reeves J; Daniel A; Martin DE; Sukpraprut-Braaten S
Cureus; 2023 Aug; 15(8):e44127. PubMed ID: 37750145
[TBL] [Abstract][Full Text] [Related]
9. Waldenstrom's Macroglobulinemia: A case report.
Kolikkat N; Moideen S; Khader A; Mohammed TP; Uvais NA
J Family Med Prim Care; 2020 Mar; 9(3):1768-1771. PubMed ID: 32509689
[TBL] [Abstract][Full Text] [Related]
10. Kidney Involvement of Patients with Waldenström Macroglobulinemia and Other IgM-Producing B Cell Lymphoproliferative Disorders.
Higgins L; Nasr SH; Said SM; Kapoor P; Dingli D; King RL; Rajkumar SV; Kyle RA; Kourelis T; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Ansell SM; Gonsalves WI; Thompson CA; Fervenza FC; Zand L; Hwa YL; Jevremovic D; Shi M; Leung N
Clin J Am Soc Nephrol; 2018 Jul; 13(7):1037-1046. PubMed ID: 29848505
[TBL] [Abstract][Full Text] [Related]
11. Management of lytic bone disease in lymphoplasmacytic lymphoma: A case report and review of the literature.
Baksh M; Jiang L; Bhatia U; Alegria V; Sher T; Roy V; Chanan-Khan A; Ailawadhi S; Parrondo RD
Clin Case Rep; 2021 Dec; 9(12):e05181. PubMed ID: 34934497
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
Elba S; Castellino A; Soriasio R; Castellino C; Bonferroni M; Mattei D; Strola G; Drandi D; Mordini N; Foglietta M; Rapezzi D; Celeghini I; Grasso M; Giordano F; Fraternali Orcioni G; Massaia M
J Med Case Rep; 2020 Jun; 14(1):75. PubMed ID: 32564775
[TBL] [Abstract][Full Text] [Related]
13. B-cell non-Hodgkin lymphoma of the breast in Waldenström's macroglobulinemia: a case report.
Esposito E; Varone V; Siani C; Di Bonito M; Melucci MT; Donzelli I; di Giacomo R; Marone U; Saponara R; Collina F; Fucito A; Avino F
Transl Cancer Res; 2023 Mar; 12(3):651-657. PubMed ID: 37033363
[TBL] [Abstract][Full Text] [Related]
14. Beyond monoclonal gammopathy of undetermined significance, clinical spectrum of immunoglobulin M gammopathy: a case series with focus on the diagnostic and management challenges.
Ashruf OS; Mirzai S; George LL; Anwer F
Int J Hematol Oncol; 2023 Jun; 12(2):IJH44. PubMed ID: 37304326
[TBL] [Abstract][Full Text] [Related]
15. A Diagnostic Dilemma: Waldenström's Macroglobulinemia/Plasma Cell Leukemia.
Sethi B; Butola KS; Kumar Y
Case Rep Pathol; 2012; 2012():271407. PubMed ID: 22991680
[TBL] [Abstract][Full Text] [Related]
16. Bing-Neel Syndrome: An Initial Manifestation of Waldenstrom Macroglobulinemia.
Lee MS; Sathe S; Valasapalli S; Grosse Perdekamp M
Cureus; 2021 Nov; 13(11):e19402. PubMed ID: 34926004
[TBL] [Abstract][Full Text] [Related]
17. IgM multiple myeloma: report of four cases and review of the literature.
Annibali O; Petrucci MT; Del Bianco P; Gallucci C; Levi A; Foà R; Avvisati G
Leuk Lymphoma; 2006 Aug; 47(8):1565-9. PubMed ID: 16966268
[TBL] [Abstract][Full Text] [Related]
18. Lytic Bone Lesions as a Prominent Feature in Waldenstrom's Macroglobulinemia.
Schlesinger N; Neustadter L; Schumacher HR
J Clin Rheumatol; 2000 Jun; 6(3):150-3. PubMed ID: 19078464
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
Tedeschi A; Conticello C; Rizzi R; Benevolo G; Laurenti L; Petrucci MT; Zaja F; Varettoni M
Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
[TBL] [Abstract][Full Text] [Related]
20. A Case of Waldenstrom's Macroglobulinemia Morphologically Resembling Plasma Cell Myeloma.
Uminski K; Houston BL; Moltzan C; Sun P
J Hematol; 2019 Mar; 8(1):26-28. PubMed ID: 32300437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
